Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


What evidence supports new fee codes for chronic disease?

February 19, 2018
  • The most robust evaluation data is available for BC. Chronic Disease Management (CDM) incentives in BC were associated with fewer hospital days, fewer admissions and readmissions, and shorter lengths of hospital stays for several of the groups for which CDM incentives were introduced: hypertension, chronic obstructive pulmonary disease, and congestive heart failure. [1]
  • After controlling for patients’ age, sex, service needs level, and continuity of care (defined as attachment to a general practice), the incentives reduced the net annual health care costs, in Canadian dollars, for patients with chronic obstructive pulmonary disease (by Can$496), hypertension (by approximately Can$308 per patient), congestive heart failure (by Can$96), but not diabetes (incentives cost about Can$148 more per patient). [2]

[1] Hollander, Kadlec, 2015

[2] Hollander, Kadlec, 2015